Literature DB >> 2453904

When should treatment of acute experimental pancreatitis be started? The early phase of bile-induced acute pancreatitis.

P G Lankisch1, U Pohl, J Otto, G Rahlf.   

Abstract

Sodium taurocholate pancreatitis in the rat is a frequently used experimental model for evaluating therapeutical regimes in this disease. It is, however, uncertain when treatment should be started, as the early phase of this experimental model and thus the time when the pancreatitis really develops is unknown. Serum and pancreatic enzymes, as well as pancreatic morphology, were therefore studied 5, 30, and 60 min after induction of sodium taurocholate pancreatitis. It was found that increase in serum enzymes and decrease in pancreatic enzymes and morphological changes characteristic for acute pancreatitis develop as early as 5 and 30 min after induction of pancreatitis. Thus, therapy in this model may be started shortly after induction of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453904     DOI: 10.1007/bf01852268

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  18 in total

1.  The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals.

Authors:  A Dabrowski; A Gabryelewicz; L Chyczewski
Journal:  Int J Pancreatol       Date:  1991-01

2.  Increased activity of group II phospholipase A2 in plasma in rat sodium deoxycholate induced acute pancreatitis.

Authors:  S Furue; Y Hori; K Kuwabara; J Ikeuchi; H Onoyama; M Yamamoto; K Tanaka
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

3.  Effects of the celecoxib on the acute necrotizing pancreatitis in rats.

Authors:  Etem Alhan; Nuri I Kalyoncu; Cengiz Ercin; Birgul Vanizor Kural
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

4.  Therapeutic effect of isovolemic hemodilution with dextran 60 on the impairment of pancreatic microcirculation in acute biliary pancreatitis.

Authors:  E Klar; C Herfarth; K Messmer
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

5.  Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.

Authors:  U Leonhardt; F Seidensticker; M Fussek; F Stöckmann; W Creutzfeldt
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

6.  Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept.

Authors:  E Klar; T Foitzik; H Buhr; K Messmer; C Herfarth
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

7.  Morphometric characteristics and homogeneity of a new model of acute pancreatitis in the rat.

Authors:  J Schmidt; K Lewandrowsi; A L Warshaw; C C Compton; D W Rattner
Journal:  Int J Pancreatol       Date:  1992-08

8.  Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas.

Authors:  E Klar; W Schratt; T Foitzik; H Buhr; C Herfarth; K Messmer
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

9.  Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis.

Authors:  T Foitzik; K Mithöfer; M J Ferraro; C Fernández-del Castillo; K B Lewandrowski; D W Rattner; A L Warshaw
Journal:  Ann Surg       Date:  1994-08       Impact factor: 12.969

10.  Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.

Authors:  U Leonhardt; A Fayyazzi; F Seidensticker; F Stöckmann; H D Söling; W Creutzfeldt
Journal:  Int J Pancreatol       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.